The role of COVID-19 prevalence and cancer preparedness on cancer statistics in the Asia–Pacific region
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
As the number of diagnosed COVID-19 cases recently exceeded 31 million globally [1], the impact of this pandemic on cancer statistics needs to be elucidated. In the Asia–Pacific region, which has an estimated 8.8 million new cancer cases and nearly half of the world’s 18.1 million new cancer cases in 2018 [2], diverse levels of COVID-19 prevalence and cancer preparedness in different countries will contribute to a wide variance in the pandemic's effect on cancer incidence and survivorship across the region.
Cancer Causes & Control , éditorial, 2019